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Pfizer Bioprocessing R&D is focused on developing enabling technologies that will reduce capital and 
operational expenses, decrease equipment scale, increase automation and utilize fewer FTEs.  To realize this 
vision, our Pilot Facility has partnered with our cell culture process development colleagues to adapt a fed batch 
platform 150L stainless steel bioreactor to run in hybrid perfusion, standard perfusion, low volume cell controlled 
perfusion, and continuous stirred tank modes.  Through adjustments to impeller configuration, sparging strategy, 
and addition ports the bioreactor was able to deliver multiple batches that produced ~3X gains in cell density 
and volumetric productivity versus conventional fed batch platform methods.   
 
 
 
 
